Colchicine in Vascular Inflammation Assessed With PET Imaging
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the effects of colchicine on vascular inflammation
measured by (FDG)-PET imaging in patients with atherosclerotic vascular disease. This effect
will also be measured by soluble plasma biomarkers. Finally, an optional pharmacogenomic
investigation will be performed to identify genetic biomarkers of patient response.